Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Somatic STAT3 mutations in CD8+ T cells of healthy blood donors carrying human T-cell leukemia virus type 2. | Haematologica | 2022 | 34706498 | PubTator, text mining | PubMed |
| Transforming growth factor-β signaling modifies the hematopoietic acute inflammatory response to drive bone marrow failure. | Haematologica | 2022 | 34706493 | PubTator, text mining | PubMed |
| Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry. | Prostate Cancer Prostatic Dis | 2022 | 34645983 | PubTator, text mining | PubMed |
| Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients. | Cancer Res Treat | 2022 | 34645131 | PubTator, text mining | PubMed |
| Utilizing flip angle/TR equivalence to reduce breath hold duration in hyperpolarized 129 Xe 1-point Dixon gas exchange imaging. | Magn Reson Med | 2022 | 34644815 | PubTator, text mining | PubMed |
| Cancer in Children With Fanconi Anemia and Ataxia-Telangiectasia-A Nationwide Register-Based Cohort Study in Germany. | J Clin Oncol | 2022 | 34597127 | PubTator, text mining | PubMed |
| Germline variant screening with targeted next generation sequencing in prostate cancer: phenotype-genotype correlation. | Turk J Med Sci | 2022 | 34579513 | PubTator, text mining | PubMed |
| Molecular and Clinical Characterization of Patients With Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy. | Clin Genitourin Cancer | 2022 | 34538582 | PubTator, text mining | PubMed |
| The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors. | J Cancer Res Clin Oncol | 2022 | 34510272 | PubTator, text mining | PubMed |
| Structure-based identification of galectin-1 selective modulators in dietary food polyphenols: a pharmacoinformatics approach. | Mol Divers | 2022 | 34482478 | PubTator, text mining | PubMed |
| Clinicopathological characteristics and genetic variations of uterine tumours resembling ovarian sex cord tumours. | J Clin Pathol | 2022 | 34348985 | PubTator, text mining | PubMed |
| Ossifying Fibroma of Non-odontogenic Origin: A Fibro-osseous Lesion in the Craniofacial Skeleton to be (Re-)considered. | Head Neck Pathol | 2022 | 34173971 | PubTator, text mining | PubMed |
| Uterine PEComas: correlation between melanocytic marker expression and TSC alterations/TFE3 fusions. | Mod Pathol | 2022 | 34131293 | PubTator, text mining | PubMed |
| SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cells. | Mol Oncol | 2022 | 34058059 | PubTator, text mining | PubMed |
| Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies. | Cancer Gene Ther | 2022 | 34045664 | PubTator, text mining | PubMed |
| Fanconi Anemia Gene Variants in Patients with Gonadal Dysfunction. | Reprod Sci | 2022 | 33977503 | PubTator, text mining | PubMed |
| Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing. | Protein Cell | 2022 | 33945139 | PubTator, text mining | PubMed |
| Pyrrolizidine alkaloids cause cell cycle and DNA damage repair defects as analyzed by transcriptomics in cytochrome P450 3A4-overexpressing HepG2 clone 9 cells. | Cell Biol Toxicol | 2022 | 33884520 | PubTator, text mining | PubMed |
| Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. | Haematologica | 2022 | 33297669 | PubTator, text mining | PubMed |
| Active DNA demethylation-The epigenetic gatekeeper of development, immunity, and cancer. | Adv Genet (Hoboken) | 2021 | 36618446 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=56